RedHill Biopharma Awarded Judgment of Approximately $8 Million Plus Costs by New York Supreme Court Read More October 28, 2024 RedHill Selected to Present Opaganib at Conference Organized by U.S. Government's JPEO-CBRND Read More February 4, 2025 ...
Inspired by you, focused on your health, and driven to deliver. Learn More Our Medicine Extraordinary medicines. Extraordinary lives. Learn More Pipeline A deep pipeline of innovation. Learn More Innovation in GI, Infectious Diseases and Oncology ...
RedHill is at the forefront of pandemic preparedness and medical countermeasures efforts, developing two novel, potentially broad-acting, host-directed, late-stage, oral, small molecule therapies, with intrinsic viral mutation-resistant properties, suitable for stockpiling and easy distribution and administ...
RedHill Biopharma 170.0 0.0(0.00%) 1日 1周 1个月 3个月 6个月 1年 5年 最大值 关键数据 编辑 更多RDHL数据指标 卖价/买价 167.60 / 170.00 昨收 169.6 开盘 168 当日幅度 165.5-170 52 周范围 0-0 量 - 平均成交量 (3个月) 339.69K 1年涨跌幅 0% 公允价值 解锁 按公允价值计的上涨潜力 ...
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole...
雪球为您提供Redhill Biopharma(RDHL)股票实时行情,资金流向,新闻资讯,研究报告,社区互动,交易信息,个股点评,公告,财务指标分析等与Redhill Biopharma(RDHL)股票相关的信息与服务.
Redhill Biopharma启动RHB-204在抗分枝杆菌亚种对称抗体阳性中度至重度克罗恩病的第二阶段研究 Redhill Biopharma启动RHB-204在分枝杆菌属可耐热型阳性中度至重度的第二阶段研究 Benzinga03/12 19:03 Redhill Biopharma将RHB-102许可给Hyloris用于全球市场。 TipRanks02/25 20:27 2023年2月25日的市场动态资讯 HIMS: ...
RedHill Biopharma Ltd.产业、业务简介 RedHill Biopharma Ltd.是以色列的一家新兴生物制药公司,主要致力于发展治疗候选人。公司获得许可后开发专利保护的新配方和现有药物组合的高级阶段。RedHill Biopharma Ltd.于2009年8月3日在以色列成立。该公司的主要治疗重点是对炎症和胃肠(GI)疾病,包括癌症和相关病症。 RedHill Bi...
Redhill Biopharma近十二个月的ebit-20.488百万 December 2019至2023的财年Redhill Biopharma的ebit为 -50.746百万 December 2019至 2023的财年,Redhill Biopharma的ebit中值为-43.201百万。 过去5年,Redhill Biopharma的ebit在June 2024达到了 -20.488百万的峰值。 Redhill Biopharma的ebit于December 2021触及5年低点,是-81....
Redhill Biopharma(RDHL) 2.56-0.04 -1.5385% 今开:2.51昨收:2.6 最高:2.62最低:2.47 涨停价:0.0跌停价:0.0 总市值:3324575.0